The main objective of this project is the development of an algorithm based on artificial intelligence (AI) that allows objective guidance and assistance in decision-making regarding the clinical management of the patient individually and guides the decision-making of health policy in the joint multidimensional analysis of the data. In order to carry it out, interdisciplinary and coordinated action and a joint and integrated analysis of the phenotypic/clinical, pathological, radiomic and genomic data of patients with metastatic cancer will be necessary. With the detailed study of the findings, the multidimensional knowledge of cancer in the Spanish population is sought from the most important angles.
The project will allow the elaboration of health strategies to prevent, initially diagnose and treat in a more cost-effective manner the most prevalent tumors at the population level.
Consortium between Eurofins Megalab S.A.U., Fundación MD Anderson International España, Genomcore S.L., Pangaea Oncology S.A., Artificial Intelligence Techniques S.L., Quibim S.L. and Atrys Health S.A.
To achieve the objectives
TSI-100206-2021-2 2021-2024This project (MIA.2021.M02.0006 2021-2024) has file number: TSI-100206-2021 and belongs to the Convocatoria Programa Misiones de Misiones de I+D en Inteligencia Artificial 2021. It is funded by the Ministry of Economic Affairs and Digital Transformation, through the Secretary of State for Digitalization and Artificial Intelligence and within the Recovery, Transformation and Resilience Plan (PRTR). It also has co-financing through the European Union – NextGenerationEU, within the framework of the Recovery and Resilience Mechanism (MRR).











